Inovio files for $50M offering amid Covid-19 vaccine hunt; Zydus Cadila signs on with XOMA on IL-2 deal
→ Inovio, the company now building a DNA vaccine against the novel coronavirus, has filed for a $50 million equity …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
